Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

CPAP CARE CLUB LLC

UEI: M44WTWJTL4M1

CPAP CARE CLUB LLC is a federal contractor, registered under UEI M44WTWJTL4M1. It has been awarded $12,904 across 1 federal contract. Primary work spans Medicinal and Botanical Manufacturing. Top awarding agencies include Department Of Justice.

Contact Information

Registration and classification details

Registration

UEI Code

M44WTWJTL4M1

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Justice$12.9K100%

Awards by NAICS

325411 - Medicinal and Botanical Manufacturing$12.9K100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in CPAP CARE CLUB LLC's top NAICS codes and agencies

NIRMATRELVIR AND RI

Solicitation # SPE2DP-26-T-4498

The contract specifies the procurement of 50 boxes of PAXLOVID, each containing 10 blister cards with three tablets each—two 150 mg nirmatrelvir tablets and one 100 mg ritonavir tablet—providing a five-day course of treatment with two daily doses per box. The product is manufactured by Pfizer Inc under part number NDC00069-5321-30 and is regulated by the FDA, requiring confirmation via EBS referral. Each box constitutes a complete unit of issue, and the medication must be shipped within 20 days to the delivery point in Williamsburg, Virginia, with no variance allowed in quantity. The shelf life is fixed at 36 months and non-extendable, with packaging required to meet MIL-STD-2073-1E standards and medical marking Standard No. 1, superseding MIL-STD-129. All shipments must be traceable, cannot use parcel post, and must comply with DLA packaging and marking requirements. The contract is issued under solicitation SPE2DP-26-T-4498 with a response deadline of August 11, 2026, and an original required delivery date of April 28, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 6 hours ago

DEADLINE

CALCIUM CHLORIDE INJEC

Solicitation # SPE2DP-26-T-4471

CALCIUM CHLORIDE INJECTION USP is procured as a 10 mL single-dose plastic syringe containing 1 gram of calcium chloride (100 mg/mL), packaged ten syringes per unit (1 PG = 10 EA), with a mandatory 24-month shelf life from the date of manufacture, no less than 21 months of which must remain at the time of delivery to the government. The product must be labeled in strict accordance with Medical Marking Standard No. 1, including the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, contract number, and lot number, and stored at 20 to 25°C (68 to 77°F). The item is regulated by the FDA and requires prior confirmation from the product specialist via EBS referral before award. Packaging must be commercial and designed to protect against damage, with exterior shipping containers ensuring safe, cost-effective transport to the delivery point. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The manufacturer is Pfizer Inc, with NDC 00409-1631-10, and the item is identified by NSN 6505-01-655-0700. Delivery is FOB destination in 20 days to Fort Campbell, Kentucky, with zero quantity variance permitted, and shipment must occur via traceable means, excluding parcel post. The contract reference is SPE2DP-26-T-4471, with an original required delivery date of August 5, 2026, and procurement governed by the DLA Master List of Technical and Quality Requirements, which take precedence over all other standards including ASTM D3951.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ANALGESIC GEL, TOPICAL

Solicitation # SPE2DP-26-T-4491

The contract solicits a topical analgesic gel containing 5% menthol USP, packaged in 4 oz tubes with 144 tubes per case, designated by NSN 6505-01-658-7643. The product is classified as flammable and must be stored at 20–25°C (68–77°F). It carries a non-extendable shelf life of 24 months and is subject to specific packaging standards under Medical Marking Standard No. 1, superseding MIL-STD-129. Each unit must be sealed in protective containers and packed in commercial shipping containers suitable for safe transport at the lowest carrier rate, with all markings compliant with medical logistics requirements. Hazard communication regulations under OSHA’s revised HCS and 29 C.F.R. 1910.1200 apply, requiring suppliers to submit approved Safety Data Sheets and compliant labels to the contracting officer before award. A current SDS must accompany each shipment and be submitted electronically to DLA.MSDS@DLA.MIL with the required cover sheet. The product must comply with 49 CFR and ICAO regulations for hazardous materials, and suppliers must train employees on these requirements. The solicitation, issued under SPE2DP-26-T-4491, has a response deadline of August 10, 2026, with delivery to Fort Campbell, Tennessee, required within 20 days of award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUMATRIPTAN SUCCINATE

Solicitation # SPE2DP-26-T-4473

Sumatriptan Succinate Tablets, 100mg, are supplied in bottles of nine tablets and are indicated for the acute treatment of migraine with or without aura in adults. The product must be stored at 20 to 25°C (68 to 77°F) and protected from light, complying with USP controlled room temperature standards. It is subject to a non-extendable 24-month shelf life under Type I (Code M) requirements, with packaging and marking mandated to adhere to MIL-STD-2073-1E and MIL-STD-129, as well as the latest Medical Marking Standard No. 1. The supply is regulated by the FDA, and contractors must provide detailed manufacturer and product information for official verification. Two line items total two bottles, with delivery required within five days to two separate military addresses: one at Joint Base Elmendorf-Richardson, Alaska, and the other at Ramstein Air Base, Germany. Both shipments are FOB destination, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The contract includes DLA-specific packaging, procurement, and logistics requirements, referencing technical standards from the DLA Master List, and is issued under solicitation SPE2DP-26-T-4473 with a required delivery date of August 5–6, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MAGNESIUM SULFATE

Solicitation # SPE2DP-26-T-4456

MAGNESIUM SULFATE 495MG/5GM oral granules in 454GM bags, sold in cases of 12 bags each, is procured under contract SPE2DP-26-T-4456 for delivery to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632 with a five-day delivery window and no tolerance for quantity variance. The product is classified as a TYPE I (CODE Q) medical item with a non-extendable shelf life of 36 months and must comply with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. All packaging must meet commercial standards as specified in DLA’s procurement requirements, ensuring each unit is sealed in protective containers and packed in exterior shipping containers suitable for safe, low-cost transport by common carrier to the destination. Palletization and labeling must adhere to DLA’s Packaging Requirements for Procurement and the latest version of Medical Marking Standard No. 1, available through DLA Troop Support or their official website. The item is identified by NSN 6505-01-714-4975 and NDC 46122-0461-43, supplied by AMERISOURCEBERGEN DRUG CORP, and shipped via traceable methods only—parcel post is prohibited. Delivery is FOB destination with inspection and acceptance also occurring at the point of delivery, and the required delivery date is August 5, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Manufacturing of CARD Casualty Response Documentation ToolThe contract is for the full production of a durable, field-ready medical documentation card designed to support casualty response operations, adhering strictly to the DLA Master List technical and quality standards. The product must be robust enough for frontline use under demanding conditions and capable of reliably conveying critical medical information in austere environments. Production will be executed as a subcontract under the Department of Defense’s Medical Supply Chain MD Surg FSF, with the place of performance located in WaterVliet, New York, at the ZIP code 12189-5000. The NAICS code 325411 indicates the work falls under pharmaceutical and medicine manufacturing, underscoring the precision and regulatory compliance required in materials and processes. The solicitation was posted on August 2, 2026, with a response deadline of August 10, 2026, allowing potential subcontractors a limited window to submit proposals. The contract type is explicitly labeled as a subcontract, meaning the winning party will be engaged by a prime contractor rather than directly by the government. There is no set-aside classification specified, indicating the opportunity is open to all eligible entities regardless of business size or status. While no point of contact is listed, interested parties can access additional details through the provided DIBBS link, which hosts the official request for quotation. The focus is squarely on delivering a standardized, high-integrity medical documentation tool that meets rigorous military specifications for reliability and performance.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Hydrocortisone Cream 2.5% (NSN 6505017157536)The contract entails the procurement and delivery of ten units of Hydrocortisone Cream 2.5% in one-ounce tubes, specifically designated by NSN 6505017157536, ensuring full compliance with FDA regulations and adherence to Department of Defense medical and logistical standards as defined by DLA. All products must meet stringent military medical requirements for quality, packaging, labeling, and shelf life to support operational readiness and field distribution. The solicitation is issued under a subcontract mechanism with a NAICS code of 325411, indicating pharmaceutical manufacturing, and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. Responses are due by August 10, 2026, with the opportunity posted on August 2, 2026, providing suppliers eight days to submit proposals. The place of performance and point of contact details are not specified, but delivery must fulfill the logistical needs of the Defense Logistics Agency. The contract is accessible through the DIBBS platform, and while no set-aside designation is listed, all offerings must be FDA-approved and aligned with the prescribed military medical specifications for use in deployed and garrison medical facilities.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Omeprazole Extended-Release Capsules (NSN 6505016247068)The contract solicits suppliers to provide FDA-approved Omeprazole Extended-Release Capsules in bulk quantities that fully comply with National Stock Number NSN 6505016247068 specifications, ensuring eligibility for procurement by the Defense Logistics Agency. The product must meet all regulatory and quality standards required for use within U.S. military medical supply chains and is intended for distribution through the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. Submission deadlines are firm, with responses due by August 10, 2026, and the solicitation is structured as a subcontract under the NAICS code 325411, which pertains to pharmaceutical and biological product manufacturing. All deliveries are to be addressed to the designated place of performance in APO, ZIP 96264-2022, with no additional office address details provided. The contract is posted on the DIBBS platform and is open to qualified manufacturers capable of meeting stringent military pharmaceutical requirements.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of NSN 6505-01-719-3181 Medical or Hazardous ItemThe contract requires the supply of a commercial item identified by NSN 6505-01-719-3181, which must meet all applicable medical, packaging, and hazardous material regulations. This item is intended for use within the Department of Defense’s medical supply chain and must be delivered in full compliance with federal standards for handling and transport of sensitive medical or hazardous goods. The work is to be performed at FPO with a ZIP code of 96675, and the contract is classified as a subcontract under NAICS code 325411, indicating the manufacturing of pharmaceutical and botanical products. The solicitation was posted on August 2, 2026, with responses due by August 10, 2026, and the official interface for details can be accessed through the DLA Dibbs platform.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Sodium Chloride Injection and Medical ConsumablesThe contract seeks a supplier to provide FDA-regulated sodium chloride injection syringes and related medical consumables that comply with strict shelf-life and packaging standards required for military medical use. The items must meet regulatory and quality benchmarks to ensure safety, sterility, and operational readiness within Department of Defense healthcare systems. Performance is scheduled to be fulfilled at the WaterVliet location with zip code 12189-5000, indicating the physical delivery point for these critical medical supplies. This is a subcontract opportunity issued under the NAICS code 325411 for pharmaceutical manufacturing and was posted on August 2, 2026, with responses due by August 10, 2026. It is managed by the Medical Supply Chain Pharm FSA under the Department of Defense and is part of the broader effort to maintain reliable, high-integrity medical inventory for U.S. military operations. Suppliers must adhere to all federal medical device and pharmaceutical regulations and deliver fully compliant products to support the readiness of deployed medical teams.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PSYLLIUM HYDROPHILIC M

Solicitation # SPE2DP-26-T-4405

The contract is for the procurement of Psyllium Hydrophilic Mucilloid in 12-gram packets, each containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per case. This product is regulated by the FDA and must be supplied with its manufacturer’s part number NDC37000-0740-87, sourced from Procter & Gamble Distributing LLC. The item has a non-extendable shelf life of 24 months and must comply with DLA’s technical and quality requirements as defined in the DLA Master List, with packaging and marking strictly governed by Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet MIL-STD-2073-1E and DLA-specific packaging requirements, ensuring secure, commercial-grade containment capable of protecting contents during transit. Delivery is FOB destination with no tolerance for quantity variance, and items must be shipped within five days of contract award using the fastest traceable means—parcel post is prohibited. The delivery address is a Navy vessel in FPO AP 96675, with specific shipping and marking instructions governed by DLA’s logistics protocols. The NSN is 6505-01-719-3181, and the contract number is SPE2DP-26-T-4405, with an original required delivery date of August 4, 2026. All bids must include the supplier and manufacturer details for FDA referral through EBS prior to award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SUMATRIPTAN SUCCINATE

Solicitation # SPE2DP-26-T-4415

Sumatriptan Succinate Tablets, 100 mg, are supplied in a bottle of nine tablets and are indicated for the acute treatment of migraine with or without aura in adults. The product must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, in compliance with USP standards. The item is regulated by the FDA and subject to strict shelf-life requirements: it has a non-extendable shelf life of 24 months as a Type I CODE M item, and must be marked according to the latest edition of Medical Marking Standard No. 1 and MIL-STD-129 for packaging and labeling. Packaging and palletization must adhere to DLA’s Packaging Requirements for Procurement and MIL-STD-2073-1E, with no tolerance for quantity variance. The contract specifies delivery FOB destination within 20 days, with inspection and acceptance occurring at the destination. The supplier is identified as MYLAN PHARMACEUTICALS INC with NDC 00378-5632-59, and the item is procured under NSN 6505-01-727-8704. Delivery is to a U.S. military address in APO AE 09094-3219, with freight originating from Ramstein, Germany. The solicitation number is SPE2DP-26-T-4415, with a required delivery date of August 4, 2026, and bid responses due by August 10, 2026. Technical and quality requirements are governed by the DLA Master List, and the contracting official must submit a referral through EBS for FDA product validation prior to award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CARD CASUALTY RESPO

Solicitation # SPE2DS-26-T-298R

The CARD CASUALTY RESPONSE DOCUMENTATION TOOL is a compact, durable card measuring 6.5 inches by 4 and 2/8 inches, constructed from card stock with a grommet and sealed in clear plastic for protection, accompanied by a 14-inch cable tie to securely fasten it to the patient. Designed for frontline responders, it captures essential data elements required for initial casualty treatment documentation. Each card includes a unique individual bar code identifier to ensure accurate tracking and record linkage. The unit of issue is singular, and the item is designated by NSN 6515-01-575-2772 with a procurement quantity of 8 units under purchase request 7017710965. Delivery is required within five days of award, with performance occurring in WaterVliet, New York, 12189-5000. The contract, issued under solicitation SPE2DS-26-T-298R, is subject to technical and quality requirements from the DLA Master List, with compliance dependent on the revision in effect at the solicitation or award date. It falls under NAICS code 325411 and is managed by the Department of Defense’s Medical Supply Chain MD Surg FSF. The item is classified as potentially containing covered defense information, and packaging must follow DLA procurement standards. Government identification must be removed from non-accepted supplies, and bidders are required to specify their source and part number. All submissions must be made prior to the response deadline of August 10, 2026, with the solicitation posted on August 2, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

HYDROCORTISONE CREA

Solicitation # SPE2DP-26-T-4438

The contract specifies the procurement of 10 units of Hydrocortisone Cream 2.5% in 1 oz tubes, manufactured by Sun Pharmaceutical Industries, Inc., with NDC number 10631-0407-01. Each unit must be packaged in compliance with the Medical Marking Standard No. 1 and MIL-STD-2073-1E, with all labeling and marking requirements strictly followed, superseding any reference to MIL-STD-129. The product is regulated by the FDA and requires a 24-month non-extendable shelf life, with storage conditions maintained at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from freezing. Delivery is required FOB destination within five days of contract award, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The shipment must be sent by the fastest traceable means, excluding parcel post, to Fort Stewart, Georgia, under the solicitation number SPE2DP-26-T-4438. Packaging must ensure safe transit via commercial carriers at the lowest cost, with each unit sealed and protected from damage. All technical and quality requirements are governed by the DLA Master List, and the contract incorporates specific DLA packaging directives including RP001 and RD003. The contract is issued under a federal procurement system with a unit of issue of EA and a total value of $10.00.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

LIDOCAINE HYDROCHLO

Solicitation # SPE2DP-26-T-4430

The contract specifies the procurement of LidoCaine Hydrochloride 2% Mucosal Jelly in single-use prefilled plastic syringes, each containing 220 mg per 11 mL, packaged in boxes of ten units. The product is a sterile topical anesthetic intended for medical use, with a non-extendable shelf life of 36 months and must comply with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards as defined in the procurement document, ensuring each unit is sealed and protected from damage, and shipped in commercial exterior containers that guarantee safe delivery at the lowest cost to the designated destination. The item is identified by NSN 6505-01-707-4169 and NDC 25021-0673-77, supplied by Sagent Pharmaceuticals, Inc., and the unit of issue is one box containing ten syringes. Delivery is required within five days FOB destination, with no variance permitted in quantity, and inspection and acceptance occur at the delivery point. The shipment is directed to USMC facilities in Palmerston, Australia, under a SOFA tariff agreement, with specific transportation and marking instructions governed by DLA procedures. The contract was issued under solicitation SPE2DP-26-T-4430, with a response deadline in August 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Timothy McCauley listed as the primary point of contact.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PSYLLIUM HYDROPHILI

Solicitation # SPE2DP-26-T-4403

The contract is for Psyllium Hydrophilic Mucilloid in 12 gm packets, each containing 25 mg potassium and 5 mg sodium, sold in units of 30 packets per package, with a total quantity of 10 packages required. The product, identified by NSN 6505-01-719-3181 and manufacturer part number NDC37000-0740-87 from Procter & Gamble Distributing LLC, is regulated by the FDA and must comply with all applicable medical and packaging standards, including the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for this item. The product has a non-extendable shelf life of 24 months under Type I (Code M) requirements, and all packaging must meet DLA’s commercial packaging and protection standards as outlined in MIL-STD-2073-1E and RP001, ensuring secure, carrier-acceptable delivery to the destination. Delivery is required FOB destination within 79 days of contract award, with no tolerance for quantity variance, and the item must be marked and packed strictly according to specified medical and defense logistics guidelines. The contract identifies the delivery point as APO AP 96260-5479, with the final destination at Camp Carroll, Korea, and the original required delivery date is December 17, 2025. Bidders must provide the exact source and part number being offered and are subject to FDA referral through EBS prior to award. All documentation and compliance are governed by the DLA Master List of Technical and Quality Requirements in effect on the solicitation issue date, and transport arrangements must follow DLAD Proc Notes C19 and C20. The solicitation, issued under contract number SPE2DP-26-T-4403, has a response deadline of August 10, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Diabetic and Low-Sugar Nutritional ProductsThe contract involves the manufacture and delivery of specialized sugar-free and low-glycemic medical nutritionals designed specifically for diabetic patients in hospital settings across Jamaica. These products must meet stringent nutritional and medical standards to support glycemic control and overall patient health within institutional care environments. The supplier is expected to ensure consistent production quality, adherence to regulatory protocols, and reliable distribution to meet the ongoing needs of healthcare facilities under the South East Regional Health Authority. This subcontract is issued under the NAICS code 325411, indicating it pertains to pharmaceutical and medicine manufacturing, and is administered by the Government of Jamaica through its health authority. The solicitation was posted on July 30, 2026, and the performance location is tied to the health authority’s operational network, though specific delivery sites are not detailed. While the contract does not specify a set-aside designation or point of contact, interested parties must navigate the official ePPS portal linked in the notice to access full procurement details and submit proposals in compliance with government procurement guidelines.

South East Regional Health Authority

POSTED

DEADLINE

Supply of High-Protein Nutritional SupplementsThe contract is for the supply of high-protein nutritional supplements designed to meet the therapeutic needs of malnourished individuals and those recovering from surgery, ensuring they receive essential protein-enriched medical foods to support recovery and overall health. The product must be formulated specifically for clinical use, delivering precise nutritional profiles to address deficiencies and promote healing in vulnerable patient populations under medical supervision. The agreement is structured as a subcontract and falls under the NAICS code 325411, indicating classification within pharmaceutical and pharmaceutical preparation manufacturing. The contracting authority is the South East Regional Health Authority under the Government of Jamaica, with the solicitation posted on July 30, 2026, and the supplies to be delivered to locations within Jamaica’s south eastern region. The contract does not involve a set-aside designation, and detailed performance location or point of contact information is not provided. All deliveries must align with medical standards for therapeutic nutrition, and the successful vendor will be expected to maintain consistent quality, regulatory compliance, and timely fulfillment to support ongoing patient care programs across the region. Access to further details is available through the official government e-procurement portal.

South East Regional Health Authority

POSTED

DEADLINE